LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Kinsella, Paul"
  2. AU="Alyaqout, Khaled"
  3. AU="J Joshua Smith"
  4. AU="Kotak, Dinesh"
  5. AU="Michael Holland"
  6. AU="Pauline, Staelen"
  7. AU="Mouna Esmaeilzadeh"
  8. AU=Congreve Miles
  9. AU="Li, Yunfeng" AU="Li, Yunfeng"
  10. AU="Shankar, Ganesh"
  11. AU="Ruginsk, Silvia G"
  12. AU="Aquilante, Francesco"
  13. AU="Dillon, Robert C"
  14. AU="Yuan Qu"
  15. AU="Dufour, A"
  16. AU="Hannus, Jill"
  17. AU="Rieber, Julia"
  18. AU="Gulmuradov, Tashpulat"
  19. AU="Romeu Fontanillas, Teresa"
  20. AU="Fleming, Renée"
  21. AU="Cao, Fang"
  22. AU="Sally J L Moore"
  23. AU="Moreno, Yolanda"
  24. AU="Vasiliy Ya. Kolyuchkin"

Suchergebnis

Treffer 1 - 10 von insgesamt 19

Suchoptionen

  1. Artikel ; Online: Parvovirus B19 in stem cell transplantation.

    Kinsella, Paul M / Yong, Michelle K / Slavin, Monica A / Hall, Victoria G

    Transplant infectious disease : an official journal of the Transplantation Society

    2023  Band 25, Heft 5, Seite(n) e14138

    Mesh-Begriff(e) Humans ; Parvovirus B19, Human ; Hematopoietic Stem Cell Transplantation/adverse effects ; Erythema Infectiosum ; Stem Cell Transplantation/adverse effects ; Parvoviridae Infections
    Sprache Englisch
    Erscheinungsdatum 2023-08-23
    Erscheinungsland Denmark
    Dokumenttyp Editorial
    ZDB-ID 1476094-0
    ISSN 1399-3062 ; 1398-2273
    ISSN (online) 1399-3062
    ISSN 1398-2273
    DOI 10.1111/tid.14138
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: A real-time PCR assay for Japanese encephalitis virus (JEV) genotype IV as a public health laboratory response to an emerging outbreak in Australia.

    Martin, Genevieve E / Tran, Thomas / Papadakis, Georgina / Kinsella, Paul / Druce, Julian / Caly, Leon / Williamson, Deborah A / Lim, Chuan Kok

    Pathology

    2023  Band 55, Heft 6, Seite(n) 869–870

    Mesh-Begriff(e) Humans ; Encephalitis Virus, Japanese/genetics ; Real-Time Polymerase Chain Reaction ; Public Health ; Genotype ; Disease Outbreaks
    Sprache Englisch
    Erscheinungsdatum 2023-04-11
    Erscheinungsland England
    Dokumenttyp Letter
    ZDB-ID 7085-3
    ISSN 1465-3931 ; 0031-3025
    ISSN (online) 1465-3931
    ISSN 0031-3025
    DOI 10.1016/j.pathol.2023.02.006
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Sentinel cluster of locally acquired Japanese encephalitis in southern Australia.

    Thorburn, Samuel / Friedman, Deborah / Burston, John / Kinsella, Paul M / Martin, Genevieve E / Williamson, Deborah A / Jackson, Justin

    Internal medicine journal

    2023  Band 53, Heft 5, Seite(n) 835–840

    Abstract: Prior to January 2022, only a single case of infection with Japanese encephalitis virus (JEV) had been reported on the Australian mainland, acquired in the northern extremity on Cape York. We report the clinical characteristics of the sentinel cluster of ...

    Abstract Prior to January 2022, only a single case of infection with Japanese encephalitis virus (JEV) had been reported on the Australian mainland, acquired in the northern extremity on Cape York. We report the clinical characteristics of the sentinel cluster of cases that confirmed the local acquisition of JEV in southern Australia along the Murray River bordering New South Wales and Victoria.
    Mesh-Begriff(e) Animals ; Humans ; Encephalitis, Japanese ; Culex ; Encephalitis Virus, Japanese ; South Australia ; Victoria
    Sprache Englisch
    Erscheinungsdatum 2023-05-03
    Erscheinungsland Australia
    Dokumenttyp Journal Article
    ZDB-ID 2045436-3
    ISSN 1445-5994 ; 1444-0903
    ISSN (online) 1445-5994
    ISSN 1444-0903
    DOI 10.1111/imj.16086
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: A Cryptic Clot.

    Williams, Eloise / Kinsella, Paul / Kahn, Jordan / Testro, Adam / Jones, Elizabeth / Jackett, Louise / Trubiano, Jason

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2021  Band 73, Heft 10, Seite(n) 940–943

    Mesh-Begriff(e) Humans ; Thrombosis
    Sprache Englisch
    Erscheinungsdatum 2021-11-10
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciab138
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.

    Shipton, Michael J / Kinsella, Paul M / Davis, Thomas / Azzato, Francesca / Taiaroa, George / Szer, Jeff / Routledge, David / Smibert, Olivia

    Bone marrow transplantation

    2022  Band 57, Heft 6, Seite(n) 1028–1030

    Mesh-Begriff(e) Brain Diseases/etiology ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Neurotoxicity Syndromes ; Stem Cell Transplantation/adverse effects
    Sprache Englisch
    Erscheinungsdatum 2022-04-11
    Erscheinungsland England
    Dokumenttyp Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 632854-4
    ISSN 1476-5365 ; 0268-3369 ; 0951-3078
    ISSN (online) 1476-5365
    ISSN 0268-3369 ; 0951-3078
    DOI 10.1038/s41409-022-01669-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective.

    Hossain, Mehrab E / Lister, David / Bartolo, Caroline / Kinsella, Paul M / Knox, James / Aldrich, Rosemary / Cowan, Raquel / Commons, Robert J

    Infectious diseases

    2021  Band 14, Seite(n) 11786337211010428

    Abstract: Background: The risk of transmission of Coronavirus Disease 2019 (COVID-19) is increasingly understood to be greatest early after symptom onset, however, factors associated with prolonged and increased risk of transmission remain unclear. In settings ... ...

    Abstract Background: The risk of transmission of Coronavirus Disease 2019 (COVID-19) is increasingly understood to be greatest early after symptom onset, however, factors associated with prolonged and increased risk of transmission remain unclear. In settings where COVID-19 prevalence is low, there may be a benefit of extending the period that patients are isolated to decrease the risk of transmission. This study explored the duration of viral shedding in such a location, in patients with mild-moderate COVID-19 disease in Ballarat, Australia.
    Methods: Patients diagnosed with COVID-19 disease using a real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay from oropharyngeal and bilateral deep nasopharyngeal sampling and managed through Ballarat Health Services between March 1 and May 1, 2020 were included. Patients were retested if they were afebrile for >72 hours, asymptomatic and >14 days since symptom onset. If positive on retesting, patients were tested every 3 to 7 days thereafter.
    Results: Patients underwent testing a median of 4 days (range 1-12) after initial symptom onset. Duration of symptoms ranged from 1 to 36 days. Positive tests were recorded up to a median of day 21 (range 6-38). Cycle thresholds were inversely correlated with time since symptom onset (
    Conclusions: This study demonstrates prolonged shedding of COVID-19 in patients with mild-moderate disease. It suggests that some patients with mild disease may have recrudescence of symptoms a week or more after their initial symptoms resolved.
    Sprache Englisch
    Erscheinungsdatum 2021-04-13
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2551443-X
    ISSN 1178-6337
    ISSN 1178-6337
    DOI 10.1177/11786337211010428
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Successful use of azithromycin for Escherichia coli-associated renal allograft malakoplakia: a report of two cases.

    Kinsella, Paul M / Smibert, Olivia C / Whitlam, John B / Steven, Mark / Masia, Ricard / Gandhi, Ronak G / Kotton, Camille N / Holmes, Natasha E

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

    2021  Band 40, Heft 12, Seite(n) 2627–2631

    Abstract: Malakoplakia is a chronic granulomatous disease associated with incomplete clearance of bacterial pathogens. A multimodal approach to therapy includes antimicrobials with intracellular activity, reduction in immunosuppression, and debulking of lesions. ... ...

    Abstract Malakoplakia is a chronic granulomatous disease associated with incomplete clearance of bacterial pathogens. A multimodal approach to therapy includes antimicrobials with intracellular activity, reduction in immunosuppression, and debulking of lesions. Azithromycin has an intracellular mechanism of action and enhanced Gram-negative activity compared to other macrolides. Despite some in vitro data to support its use, there are no clinical breakpoints or epidemiological cut-off values for most Enterobacterales from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) or the Clinical and Laboratory Standards Institute (CLSI). We present two cases, previously unreported, of Escherichia coli associated renal allograft malakoplakia successfully treated with azithromycin.
    Mesh-Begriff(e) Allografts/microbiology ; Anti-Bacterial Agents/administration & dosage ; Azithromycin/administration & dosage ; Escherichia coli/drug effects ; Escherichia coli/genetics ; Escherichia coli/physiology ; Escherichia coli Infections/drug therapy ; Escherichia coli Infections/microbiology ; Female ; Humans ; Kidney Transplantation/adverse effects ; Malacoplakia/drug therapy ; Malacoplakia/etiology ; Malacoplakia/microbiology ; Microbial Sensitivity Tests ; Middle Aged ; Postoperative Complications/drug therapy ; Postoperative Complications/etiology ; Postoperative Complications/microbiology
    Chemische Substanzen Anti-Bacterial Agents ; Azithromycin (83905-01-5)
    Sprache Englisch
    Erscheinungsdatum 2021-05-14
    Erscheinungsland Germany
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 603155-9
    ISSN 1435-4373 ; 0934-9723 ; 0722-2211
    ISSN (online) 1435-4373
    ISSN 0934-9723 ; 0722-2211
    DOI 10.1007/s10096-021-04270-x
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia.

    Kinsella, Paul / Moso, Michael / Martin, Genevieve / Karapangiotidis, Theo / Karamalakis, Di / Nicholson, Suellen / Batty, Mitch / Jackson, Kathy / Marsland, Madeleine / Thomson, Tilda / Manoharan, Lakshmi / O'brien, Helen / Friedman, N Deborah / Bond, Katherine / Williamson, Deborah A / Lim, Chuan Kok

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2023  Band 168, Seite(n) 105580

    Abstract: The unexpected recent emergence of Japanese encephalitis virus (JEV) genotype IV in multiple southern states of Australia necessitated an evaluation of JEV serological tests suitable for diagnosing acute infection and for seroprevalence studies. This ... ...

    Abstract The unexpected recent emergence of Japanese encephalitis virus (JEV) genotype IV in multiple southern states of Australia necessitated an evaluation of JEV serological tests suitable for diagnosing acute infection and for seroprevalence studies. This study examined the analytical and clinical performance of two high-throughput JEV assays, Euroimmun immunofluorescence assay (IFA) and Euroimmun enzyme-linked immunosorbent assay (ELISA), across four cohorts; (1) surveillance of piggery workers in outbreak areas, (2) surveillance of residents in outbreak areas, (3) acute JEV infection and (4) post-JEV vaccination. ELISA and IFA IgM demonstrated minimal cross-reactivity (0-1.8%) with other endemic flaviviruses, with high sensitivity (100%) for acute JEV infection in this low endemicity setting. Differences in IgG serodynamics between the two assays suggest convalescent and paired testing with IgM are critical in diagnosing acute infection. High assay concordance was observed between ELISA and IFA when used in serosurveillance (97.4% agreement, Cohen' κ 0.74 [95% CI 0.614-0.860]) and vaccination cohorts (91.1% agreement, Cohen's κ 0.806 [95% CI 0.672-0.941]). In conclusion, this study highlights the clinical & epidemiological applications and limitations of these two commercial JEV assays.
    Sprache Englisch
    Erscheinungsdatum 2023-09-09
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2023.105580
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settings.

    Higgs, Charlie / Sherry, Norelle L / Seemann, Torsten / Horan, Kristy / Walpola, Hasini / Kinsella, Paul / Bond, Katherine / Williamson, Deborah A / Marshall, Caroline / Kwong, Jason C / Grayson, M Lindsay / Stinear, Timothy P / Gorrie, Claire L / Howden, Benjamin P

    Nature communications

    2022  Band 13, Heft 1, Seite(n) 509

    Abstract: Vancomycin-resistant Enterococcus faecium (VREfm) is a major nosocomial pathogen. Identifying VREfm transmission dynamics permits targeted interventions, and while genomics is increasingly being utilised, methods are not yet standardised or optimised for ...

    Abstract Vancomycin-resistant Enterococcus faecium (VREfm) is a major nosocomial pathogen. Identifying VREfm transmission dynamics permits targeted interventions, and while genomics is increasingly being utilised, methods are not yet standardised or optimised for accuracy. We aimed to develop a standardized genomic method for identifying putative VREfm transmission links. Using comprehensive genomic and epidemiological data from a cohort of 308 VREfm infection or colonization cases, we compared multiple approaches for quantifying genetic relatedness. We showed that clustering by core genome multilocus sequence type (cgMLST) was more informative of population structure than traditional MLST. Pairwise genome comparisons using split k-mer analysis (SKA) provided the high-level resolution needed to infer patient-to-patient transmission. The more common mapping to a reference genome was not sufficiently discriminatory, defining more than three times more genomic transmission events than SKA (3729 compared to 1079 events). Here, we show a standardized genomic framework for inferring VREfm transmission that can be the basis for global deployment of VREfm genomics into routine outbreak detection and investigation.
    Mesh-Begriff(e) Anti-Bacterial Agents ; Bacterial Proteins/genetics ; Bacterial Typing Techniques ; Carbon-Oxygen Ligases/genetics ; Cross Infection/epidemiology ; Cross Infection/transmission ; Delivery of Health Care ; Disease Outbreaks ; Enterococcus faecium/classification ; Enterococcus faecium/genetics ; Enterococcus faecium/isolation & purification ; Genome, Bacterial ; Genomics ; Gram-Positive Bacterial Infections/epidemiology ; Gram-Positive Bacterial Infections/microbiology ; Gram-Positive Bacterial Infections/transmission ; Humans ; Multilocus Sequence Typing ; Phylogeny ; Vancomycin ; Vancomycin-Resistant Enterococci/classification ; Vancomycin-Resistant Enterococci/genetics ; Vancomycin-Resistant Enterococci/isolation & purification ; Whole Genome Sequencing
    Chemische Substanzen Anti-Bacterial Agents ; Bacterial Proteins ; VanA ligase, Bacteria ; Vancomycin (6Q205EH1VU) ; Carbon-Oxygen Ligases (EC 6.1.-)
    Sprache Englisch
    Erscheinungsdatum 2022-01-26
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-28156-4
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.

    Lee, Wen Shi / Tan, Hyon-Xhi / Reynaldi, Arnold / Esterbauer, Robyn / Koutsakos, Marios / Nguyen, Julie / Amarasena, Thakshila / Kent, Helen E / Aggarwal, Anupriya / Turville, Stuart G / Taiaroa, George / Kinsella, Paul / Liew, Kwee Chin / Tran, Thomas / Williamson, Deborah A / Cromer, Deborah / Davenport, Miles P / Kent, Stephen J / Juno, Jennifer A /
    Khoury, David S / Wheatley, Adam K

    Science advances

    2023  Band 9, Heft 29, Seite(n) eadg5301

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection of vaccinated individuals is increasingly common with the circulation of highly immune evasive and transmissible Omicron variants. Here, we report the dynamics and ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection of vaccinated individuals is increasingly common with the circulation of highly immune evasive and transmissible Omicron variants. Here, we report the dynamics and durability of recalled spike-specific humoral immunity following Omicron BA.1 or BA.2 breakthrough infection, with longitudinal sampling up to 8 months after infection. Both BA.1 and BA.2 infections robustly boosted neutralization activity against the infecting strain while expanding breadth against BA.4, although neutralization activity was substantially reduced for the more recent XBB and BQ.1.1 strains. Cross-reactive memory B cells against both ancestral and Omicron spike were predominantly expanded by infection, with limited recruitment of de novo Omicron-specific B cells or antibodies. Modeling of neutralization titers predicts that protection from symptomatic reinfection against antigenically similar strains will be durable but is undermined by new emerging strains with further neutralization escape.
    Mesh-Begriff(e) Humans ; Antibodies, Neutralizing ; Breakthrough Infections ; COVID-19 ; SARS-CoV-2
    Chemische Substanzen Antibodies, Neutralizing
    Sprache Englisch
    Erscheinungsdatum 2023-07-21
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adg5301
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang